Dynavax Technologies Corporation (DVAX)
Symbol Info
Listed Symbol DVAX
Name Dynavax Technologies Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $8,198,000
Latest Fiscal EPS $-2.55
Price Info
21 Day Moving Average $4.0526
21 Day EMA $3.970000
50 Day Moving Average $4.0199
50 Day EMA $4.063820
200 Day EMA $6.322820
200 Day Moving Average 6.371080
52 Week High $13.75
52 Week Low $2.60
52 Week Change $-64.816500
Alpha -0.003624
Beta 0.4186
Standard Deviation 0.221171
R2 0.004229
Periods 60
Share Information
10 Day Average Volume 1,007,576
20 Day Average Volume 1,291,202
30 Day Average Volume 1,416,336
50 Day Average Volume 1,614,759
Outstanding Shares 83,679,729
Float Shares 81,775,799
Percent Float 97.72%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 286
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 9,007,773
Institute Holdings Percent -
Institute Sold Previous 3 Months 9,968,577
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,903,930
Price Change
7 Day Price Change $0.2450001
7 Day Percent Change 6.65%
21 Day Price Change $-0.6499999
21 Day Percent Change -14.19%
30 Day Price Change $-0.9199998
30 Day Percent Change -18.97%
Month To Date Price Change $0.3550
Month To Date Percent 9.93%
90 Day Price Change $0.150000
90 Day Percent Change 3.97%
Quarter To Date $0.355000
Quarter To Date Percent 9.93%
180 Day Price Change $-3.08
180 Day Percent Change -43.94%
200 Day Price Change $-3.24
200 Day Percent Change -45.19%
Year To Date $-5.219999
Year To Date Percent -57.05%
Profile
Description Dynavax Technologies Corp is a clinical-stage biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. It's current product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. Dynavax operates in the business segment the discovery and development of biopharmaceutical products. Its Toll-like Receptor Immune Modulation Platform technology play a vital role in innate immunity and subsequent adaptive immunity. Signaling through these receptors is triggered by the binding of a variety of pathogen-associated molecules and is essential to the generation of innate immunity.
Details
Issue Type CS
Market Cap $328,861,335
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 83,679,729
CEO
Employees 249
Last Audit UQ
Classification
CIK 0001029142
Industry Biotechnology
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 2929 Seventh Street
Suite 100
Berkeley, CA 94710-2753
Website http://www.dynavax.com
Facisimile +1 510 848-1327
Telephone +1 510 848-5100
Email IR@dynavax.com
Key Ratios
Profitability
EBIT Margin -719.6
EBITDA Margin -633.7
Pre-Tax Profit Margin -7,103
Profit Margin Cont -
Gross Margin 3.10
Profit Margin TOT -
Income Statements
Revenue $19,392,000
Revenue Per Share $0.2317
Revenue 3 Years $21.68
Revenue 5 Years $-11.59
Valuation Measures
PE Ratio -
Enterprise Value $402,154,726
Price To Sales 16.958609
Price To Free Cash -2.9
PE High Last 5 Years -
Price To Book 22.4
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 286.8
Financial Strength
Total Debt To Equity 20.0
Int Coverage -11.7
Current Ratio 4.3
Leverage Ratio 27.2
Quick Ratio 3.3
Long Term Debt To Capital 0.95
Assets
Receivables Turnover 3.2
Invoice Turnover 0.80
Assets Turnover -
Management Effectiveness
Return Assets -61.36
Return On Equity -229.57
Return On Capital -67.87
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DVAX
Dynavax Te..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.